R&D
Psychedelic treatments on cusp of approval, but questions re...
There is a new wave of psychedelic treatment moving through clinical trials targeting mental health conditions, and they are showing strong efficacy.
Market Access
Reuters Pharma Europe 2024 – Day One
We are back in Barcelona for Reuters Pharma 2024, bringing you all the highlights and talking points from Day One of the conference. Stay tuned for updates throughout the day.
Market Access
Reuters Pharma Europe 2024
From the 16th to the 18th of April, industry leaders will gather in one of Spain’s most iconic cities as Reuters Pharma Europe returns for 2024.
Market Access
Advancing medicine requires more secure supply chains
We stand at the threshold of a new era for pharmaceutical supply chains, driven by breakthroughs in personalised medicine, the rising prevalence of biologics, and the integration of digital
Sales & Marketing
Changing Faces: Agency, consultancy, and investor hires from...
Another light month in March on the agency and investor side, but there are a few appointments worth noting.
Editor's Picks
Editor's Picks
